A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of DC-853 in Healthy Participants
Clinical trial NCT06937411 · COMPLETED
Trial details
- NCT number
- NCT06937411
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-13
- Primary completion
- 2023-10-30
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.